Trials / Recruiting
RecruitingNCT06585072
Pancreatic Cancer and Diabetes Mellitus
Prospective Cohort Study on Endo-Exdo Secretory Function Alterations and All-round Outcomes After Pancreatic Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Shanghai Changzheng Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are: 1. Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same? 2. Are alterations in endocrine and exdocrine secretory function in patients with pancreatic surgery associated with all-round outcomes? All patients with pancreatic surgery have been given the standardized treatment for the condition. The reasearchers will summarize the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) during different surgical procedures to explore the association between alternations in endocrine and exdocrine secrectory function and all-round outcomes.
Detailed description
Investigators will prospectively collect data from patients with pancreatic cancer after surgery in participant centers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data. | All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data. |
Timeline
- Start date
- 2025-01-03
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2024-09-05
- Last updated
- 2025-07-01
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06585072. Inclusion in this directory is not an endorsement.